Sermonix Pharmaceuticals

Columbus, United States · $66.0M raised

Headquarters
Columbus
Total Funding
$66.0M
Last Round
$40.0M Venture RoundNov 2021
Rounds
2

About

Sermonix Pharmaceuticals is a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC). The company's lead candidate, lasofoxifene, is being evaluated as a neoadjuvant endocrine therapy in molecularly selected HR+/HER2-, locally advanced breast cancer in a Phase 2 trial with Quantum Leap Healthcare Collaborative, and has shown promising early activity in suppressing the Ki67 protein in both premenopausal and postmenopausal patients.

Summary

Sermonix Pharmaceuticals is a Biotech company based in Columbus, United States. It has raised $66.0M in total across 2 rounds, most recently a $40.0M Venture Round round in Nov 2021. Investors include Wild Family Office.

Funding History

Venture RoundVenture RoundNov 2021
$40.0M

Sign up to see all 2 rounds

Series A through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sermonix Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/sermonix-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/sermonix-pharmaceuticals" alt="Sermonix Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>